NO20002176L - Diagnostikk og terapi av kronisk obstruktiv luftveissykdom - Google Patents

Diagnostikk og terapi av kronisk obstruktiv luftveissykdom

Info

Publication number
NO20002176L
NO20002176L NO20002176A NO20002176A NO20002176L NO 20002176 L NO20002176 L NO 20002176L NO 20002176 A NO20002176 A NO 20002176A NO 20002176 A NO20002176 A NO 20002176A NO 20002176 L NO20002176 L NO 20002176L
Authority
NO
Norway
Prior art keywords
chronic obstructive
diagnosis
therapy
obstructive airway
airway disease
Prior art date
Application number
NO20002176A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002176D0 (no
Inventor
Gordon W Duff
Marco Giovine
Peter J Barnes
Simon Lim
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9723553.5A external-priority patent/GB9723553D0/en
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Publication of NO20002176D0 publication Critical patent/NO20002176D0/no
Publication of NO20002176L publication Critical patent/NO20002176L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20002176A 1997-11-07 2000-04-27 Diagnostikk og terapi av kronisk obstruktiv luftveissykdom NO20002176L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9723553.5A GB9723553D0 (en) 1997-11-07 1997-11-07 Prediction of the risk of chronic obstructive airway disease
US09/005,923 US6140047A (en) 1997-11-07 1998-01-12 Method and kit for predicting susceptibility to asthma
PCT/US1998/023721 WO1999024615A2 (en) 1997-11-07 1998-11-09 Diagnostics and therapeutics for chronic obstructive airway disease

Publications (2)

Publication Number Publication Date
NO20002176D0 NO20002176D0 (no) 2000-04-27
NO20002176L true NO20002176L (no) 2000-07-05

Family

ID=26312564

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002176A NO20002176L (no) 1997-11-07 2000-04-27 Diagnostikk og terapi av kronisk obstruktiv luftveissykdom

Country Status (13)

Country Link
EP (1) EP1029079B1 (de)
JP (1) JP2001522586A (de)
AT (1) ATE383438T1 (de)
AU (1) AU760856B2 (de)
BR (1) BR9813950A (de)
CA (1) CA2308570A1 (de)
ES (1) ES2297900T3 (de)
HU (1) HUP0301197A2 (de)
IL (1) IL135957A0 (de)
NO (1) NO20002176L (de)
PL (1) PL340624A1 (de)
TR (1) TR200001263T2 (de)
WO (1) WO1999024615A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251598B1 (en) 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
WO2000060117A2 (en) * 1999-04-02 2000-10-12 Interleukin Genetics, Inc. Prediction of risk of interstitial lung disease
WO2001021639A1 (en) * 1999-09-22 2001-03-29 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the interleukin-1 beta gene
WO2002000933A2 (en) * 2000-06-23 2002-01-03 Interleukin Genetics, Inc. Screening assays for identifying modulators of the inflammatory or immune responses
US20050159590A1 (en) * 2003-08-25 2005-07-21 Galit Rotman Variants of interleukin-1 receptor antagonist: compositions and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001997A1 (en) * 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease

Also Published As

Publication number Publication date
AU760856B2 (en) 2003-05-22
WO1999024615A2 (en) 1999-05-20
PL340624A1 (en) 2001-02-12
EP1029079A2 (de) 2000-08-23
IL135957A0 (en) 2001-05-20
EP1029079B1 (de) 2008-01-09
TR200001263T2 (tr) 2000-12-21
WO1999024615A3 (en) 1999-09-16
ATE383438T1 (de) 2008-01-15
JP2001522586A (ja) 2001-11-20
ES2297900T3 (es) 2008-05-01
CA2308570A1 (en) 1999-05-20
HUP0301197A2 (hu) 2003-07-28
BR9813950A (pt) 2000-09-26
AU1386399A (en) 1999-05-31
NO20002176D0 (no) 2000-04-27

Similar Documents

Publication Publication Date Title
ATE324119T1 (de) Verwendung von saccharid-konjugaten
FI20000720A7 (fi) Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi
DE69627814D1 (de) System zum bereitstellen eines bios für den hauptrechner
EP0836723A4 (de) Virtuelles medizinisches instrument zum midizinischen diagnostiktesten von patienten
PT1333887E (pt) Metodo de tratamento de desordens musculares
IT1303246B1 (it) Procedimento per l'installazione e/o la verifica del software per unsistema di computer prodotto su ordinazione, e sistema di computer per
DE69633645D1 (de) Vorrichtung zum Verabreichen von Medikamenten
KR950012484U (ko) 컴퓨터 주변기기용 체결장치
NO975157D0 (no) Elektronisk betalingssystem med flere betalingsenheter samt relatert fremgangsmåte
AU6416198A (en) Diagnostic means useful for predictive assessment of human hepatocellular carc inoma disease (hcc), as well as diagnostic methods using the same
NO994915L (no) Fremgangsmåter for diagnostisering av kliniske undertyper av Crohn's sykdom med karakteristisk evne til å gi respons på anti-Thl-cytokinterapi
AU2991697A (en) Methods of diagnosing clinical subtypes of crohn's disease
BR9607544A (pt) Fluximetro de massa com efeito coriolos que usa rotores concêntricos
EP0723460A4 (de) Gentherapie für das nervensystems
DE69601813D1 (de) Fehlertolerante Rechnervorrichtung
EP0883809A4 (de) Verfahren zur diagnostik von prostata-adenokarzinome
NO20002176L (no) Diagnostikk og terapi av kronisk obstruktiv luftveissykdom
BR0012318A (pt) Compostos semelhantes a amino ceramida e métodos terapêuticos de uso
LU90171B1 (fr) Dispositif de protection de la membrane d'un stethoscope medical destiné à créer un écran microbiologique
IE782353L (en) Ethyl 2-aryl allophanates, medicaments
KR970023107U (ko) 파워트레인도킹용 기준핀을 갖는 서브프레임
KR960024500U (ko) 원고대가 내장된 컴퓨터용 모니터
ITCR950009A1 (it) Pad per computers portatili
ITCR950002V0 (it) Pad per computers portatili
KR970025433U (ko) 컴퓨터와의인터페이스가가능한cd-rom내장멀티형cd플레이어

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application